×
About 3,268 results

ALLMedicine™ Liver Transplants Center

Research & Reviews  1,463 results

Utilization of Hepatitis C Viremic Donors for Liver Transplant Recipients without Hepat...
https://doi.org/10.1111/tid.13466
Transplant Infectious Disease : an Official Journal of the Transplantation Society; Said A, Weiss M et. al.

Sep 15th, 2020 - We report our experience utilizing liver donors with HCV Viremia (RNA+) for HCV negative recipients (HCV D+R-) at a Veterans Affairs (VA) transplant center. In 2018 we introduced an informed consent process for HCV D+R- liver transplants. Eight HC...

Predicting Early Extubation after Liver Transplantation: External Validation and Improv...
https://doi.org/10.1097/TP.0000000000003452
Transplantation Haque ME, Badenoch AD et. al.

Sep 15th, 2020 - Early extubation of liver transplantation recipients is a cornerstone of Fast Track (FT) pathways. Identifying suitable candidates has previously been accomplished using peri-operative variables to develop a FT probability score. The objective of ...

Immune benefit of combined heart and liver transplantation.
https://doi.org/10.1097/MOT.0000000000000801
Current Opinion in Organ Transplantation; Ortega-Legaspi JM, Hoteit M et. al.

Sep 3rd, 2020 - Understanding the mechanisms involved in immune protection provided by a hepatic allograft is imperative as further therapies for highly sensitized patients could be developed and thus expanding the donor pool and improving outcomes. The clinical ...

Post-operative assessment in patients after liver transplantation: imaging parameters a...
https://doi.org/10.1007/s00330-020-07124-w
European Radiology; Chang WC, M Yeh B et. al.

Aug 30th, 2020 - To identify post-liver transplant CT findings which predict graft failure within 1 year. We evaluated the CT scans of 202 adult liver transplants performed in our institution who underwent CT within 3 months after transplantation. We recorded CT f...

Carrying on with liver transplantation during the COVID-19 emergency: Report from piedm...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7413117
Clinics and Research in Hepatology and Gastroenterology; Saracco M, Martini S et. al.

Aug 29th, 2020 - The COVID-19 pandemic is an emergency worldwide. In Italy, liver transplant activity was carried on, but despite all efforts, a 25% reduction of procured organs has already been observed during the first 4 weeks of the outbreak. To analyze if our ...

see more →

Guidelines  1 results

Evaluation for Liver Transplantation in Adults: 2013 Practice Guideline by the AASLD and the...
https://www.aasld.org/sites/default/files/guideline_documents/141020_Guideline_Evaluation_Adult_LT_4UFb_2015.pdf
Paul Martin

Dec 31st, 2012 - Liver disease is the twelfth commonest cause of mortality in adults in the United States, resulting in 34,000 deaths annually from cirrhosis. 7 In addition, the rising incidence of HCC in the United States is reflected in an increasing number of de.

see more →

Drugs  75 results see all →

Clinicaltrials.gov  1,629 results

Utilization of Hepatitis C Viremic Donors for Liver Transplant Recipients without Hepat...
https://doi.org/10.1111/tid.13466
Transplant Infectious Disease : an Official Journal of the Transplantation Society; Said A, Weiss M et. al.

Sep 15th, 2020 - We report our experience utilizing liver donors with HCV Viremia (RNA+) for HCV negative recipients (HCV D+R-) at a Veterans Affairs (VA) transplant center. In 2018 we introduced an informed consent process for HCV D+R- liver transplants. Eight HC...

Predicting Early Extubation after Liver Transplantation: External Validation and Improv...
https://doi.org/10.1097/TP.0000000000003452
Transplantation Haque ME, Badenoch AD et. al.

Sep 15th, 2020 - Early extubation of liver transplantation recipients is a cornerstone of Fast Track (FT) pathways. Identifying suitable candidates has previously been accomplished using peri-operative variables to develop a FT probability score. The objective of ...

Immune benefit of combined heart and liver transplantation.
https://doi.org/10.1097/MOT.0000000000000801
Current Opinion in Organ Transplantation; Ortega-Legaspi JM, Hoteit M et. al.

Sep 3rd, 2020 - Understanding the mechanisms involved in immune protection provided by a hepatic allograft is imperative as further therapies for highly sensitized patients could be developed and thus expanding the donor pool and improving outcomes. The clinical ...

Post-operative assessment in patients after liver transplantation: imaging parameters a...
https://doi.org/10.1007/s00330-020-07124-w
European Radiology; Chang WC, M Yeh B et. al.

Aug 30th, 2020 - To identify post-liver transplant CT findings which predict graft failure within 1 year. We evaluated the CT scans of 202 adult liver transplants performed in our institution who underwent CT within 3 months after transplantation. We recorded CT f...

Carrying on with liver transplantation during the COVID-19 emergency: Report from piedm...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7413117
Clinics and Research in Hepatology and Gastroenterology; Saracco M, Martini S et. al.

Aug 29th, 2020 - The COVID-19 pandemic is an emergency worldwide. In Italy, liver transplant activity was carried on, but despite all efforts, a 25% reduction of procured organs has already been observed during the first 4 weeks of the outbreak. To analyze if our ...

see more →

News  95 results

AASLD: Liver transplants should proceed despite COVID-19
https://www.mdedge.com/gihepnews/article/220026/coronavirus-updates/aasld-liver-transplants-should-proceed-despite-covid-19?channel=63993
M. Alexander Otto, MDedge News

Apr 1st, 2020 - In liver transplant recipients or patients with autoimmune hepatitis on immunosuppressive therapy, acute cellular rejection or disease flare should not be presumed in the face of active coronavirus disease 2019 (COVID-19), according to the America.

Gilead's NASH combination treatment fails mid-stage study
https://www.reuters.com/article/us-gilead-sciences-nash/gileads-nash-combination-treatment-fails-mid-stage-study-idUSKBN1YK18S

Dec 16th, 2019 - (Reuters) - Gilead Sciences Inc said on Monday all combinations of its three drugs to treat NASH were unsuccessful in a mid-stage study, the latest failure in a string of trials seeking to develop the first approved treatment for the fatty liver d...

Study links hepatitis, higher mortality post liver transplant
https://www.mdedge.com/jcomjournal/article/211752/hepatology/study-links-hepatitis-higher-mortality-post-liver-transplant?channel=302
Richard Mark Kirkner

Nov 6th, 2019 - Liver transplant for the three predominant autoimmune liver diseases – primary biliary cholangitis, primary sclerosing cholangitis, and autoimmune hepatitis – has been known to have favorable outcomes overall, but little evidence comparing cholang.

Liver donation for transplant misunderstood, underutilized
https://www.reuters.com/article/us-health-liver-donation/liver-donation-for-transplant-misunderstood-underutilized-idUSKCN1TK32X

Jun 19th, 2019 - (Reuters Health) - Lack of knowledge among community physicians may be keeping them from raising the possibility of living donor transplants with their patients with liver disease, new survey data suggest. And misperceptions among the general publ...

ALD Leading Cause of U.S. Liver Transplants
https://www.medpagetoday.com/gastroenterology/livertransplantation/77555

Jan 22nd, 2019 - The proportion of U.S. liver transplants for alcoholic liver disease (ALD) rose steadily from 2002 to 2016, making ALD the leading indication for liver transplant, researchers reported. In 2002, ALD accounted for 24.2% of all U.S. liver transplant...

see more →

Patient Education  5 results see all →